—

venBio Partners LLC

Q4 2025 13F Holdings

  • Location
    san francisco, CA
  • Num holdings

    6

  • Value ($000)

    $216,273

  • Date Filed
    02/17/2026
  • Form type
    13F-HR
  • CIK
    0001776382
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
---

PHARVARIS N V

COM
N69605108
$128.74M
60 %

4,639,304

A
ALMS

ALUMIS INC

COM
022307102
$45.09M
21 %

4,619,803

H
HRMY

HARMONY BIOSCIENCES HLDGS IN

COM
413197104
$18.31M
9 %

489,194

A
ALXO

ALX ONCOLOGY HLDGS INC

COM
00166B105
$10.96M
5 %

9,699,925

---

LYELL IMMUNOPHARMA INC

COM NEW
55083R203
$10.39M
5 %

337,697

---

ARTIVA BIOTHERAPEUTICS INC

COM
04317A107
$2.78M
1 %

648,507

Rows Per Page
10
  • 5
  • 10
  • 20
  • 30
  • 50
  • 100
1 - 6 of 6